🔗 Permalink

Assignee profile:

BIOSCEPTRE (AUST) PTY LTD

City:

NORTH RYDE

Country:

Australia

Published Applications:

Last publication date:

2022-10-06

Patent Grants:

Last grant date:

2024-10-29

Top Inventors for applications by BIOSCEPTRE (AUST) PTY LTD

These are the the leading inventors for applications assigned to BIOSCEPTRE (AUST) PTY LTD:

Julian Alexander Barden 8 North Ryde, Australia
Angus Gidley-Baird 5 North Ryde, Australia
Neil Brewis 3 Stevenage, United Kingdom
Steven GRANT 3 Cambridge, United Kingdom

Philip Jones 3 Cambridge, United Kingdom
Julian Alexander BARDEN 2 New South Wales, Australia
Xiaojuan GONG 2 New South Wales, Australia
Minoo J MOGHADDAM 2 New South Wales, Australia

Angus Gidley-Baird 2 North Ryde, NSW, Australia
Julian Alexander Barden 2 North Ryde, NSW, Australia
Timothy John Sadlon 1 Maylands, Australia
Justin T. Coombs 1 Wattle Park, Australia

Timothy J. Sadlon 1 Maylands, Australia
Simon C. Barry 1 Longwood, Australia
Simon Charles Barry 1 Longwood, Australia
Justin Taylor Coombs 1 Wattle Park, Australia

Recent patent applications by BIOSCEPTRE (AUST) PTY LTD

BIOSCEPTRE (AUST) PTY LTD based in NORTH RYDE, AU has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-10-06 ✅ Patent 12,129,295 granted on 2024-10-29

US20220315652A1

Chemistry; metallurgy

Anti P2X7 receptor antibodies and fragments thereof

#2 | 2022-08-11 ✅ Patent 12,097,265 granted on 2024-09-24

US20220249692A1

Human necessities

Cytotoxic particles for targeting P2X7 receptor

#3 | 2020-03-05

US20200071419A1

Chemistry; metallurgy

ANTIBODIES TO NON-FUNCTIONAL P2X7 RECEPTOR

#4 | 2019-12-05 ✅ Patent 12,121,539 granted on 2024-10-22

US20190365805A1

Human necessities

Chimeric antigen receptors and uses thereof

#5 | 2019-07-25 ✅ Patent 10,543,262 granted on 2020-01-28

US20190224290A1

Human necessities

Combination therapy utilizing P2X7 peptides

#6 | 2019-07-04 ✅ Patent 11,260,131 granted on 2022-03-01

US20190201545A1

Human necessities

Cytotoxic particles for targeting P2X7 receptor

#7 | 2019-02-07 ✅ Patent 10,988,532 granted on 2021-04-27

US20190040129A1

Chemistry; metallurgy

Anti P2Xreceptor antibodies and fragments thereof

#8 | 2018-09-20 ✅ Patent 10,597,451 granted on 2020-03-24

US20180265580A1

Chemistry; metallurgy

Methods of treating cancer with a P2X7 peptide

#9 | 2017-11-16 ✅ Patent 10,450,380 granted on 2019-10-22

US20170327592A1

Chemistry; metallurgy

Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor

#10 | 2017-11-16 ✅ Patent 10,053,508 granted on 2018-08-21

US20170327576A1

Chemistry; metallurgy

Anti P2X7 receptor antibodies and fragments thereof

#11 | 2015-10-01 ✅ Patent 9,663,584 granted on 2017-05-30

US20150274839A1

Chemistry; metallurgy

Antibodies to non-functional P2X7 receptor

Also check out BIOSCEPTRE (AUST) PTY LTD's (North Ryde, Australia) applicant profile with 9 patent applications submitted.

AssigneeID:

151223 ⎘